Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 6,079 | 3,947 | 5,090 | 3,474 | 3,763 |
| Cost of Goods | 1,249 | 763 | 951 | 699 | 454 |
| Gross Profit | 4,830 | 3,184 | 4,139 | 2,774 | 3,309 |
| Operating Expenses | 46,716 | 42,052 | 43,210 | 37,835 | 36,785 |
| Operating Income | -41,637 | -38,105 | -38,121 | -34,361 | -33,022 |
| Interest Expense | 4,029 | 2,090 | 2,093 | 2,053 | 531 |
| Other Income | -9,571 | 689 | 823 | 809 | 334 |
| Pre-tax Income | -55,237 | -39,506 | -39,391 | -35,605 | -33,219 |
| Net Income Continuous | -55,237 | -39,506 | -39,391 | -35,605 | -33,219 |
| Net Income | $-55,237 | $-39,506 | $-39,391 | $-35,605 | $-33,219 |
| EPS Basic Total Ops | -11.50 | -8.00 | -8.50 | -8.00 | -7.50 |
| EPS Basic Continuous Ops | -11.45 | -8.20 | -8.36 | -7.80 | -7.67 |
| EPS Diluted Total Ops | -11.50 | -8.00 | -8.50 | -8.00 | -7.50 |
| EPS Diluted Continuous Ops | -11.45 | -8.20 | -8.36 | -7.80 | -7.67 |
| EBITDA(a) | $-41,325 | $-37,878 | $-37,905 | $-34,168 | $-32,926 |